-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Upgrades Option Care Health to Buy, Raises Price Target to $40

Benzinga·04/30/2025 11:26:59
Listen to the news
UBS analyst A.J. Rice upgrades Option Care Health (NASDAQ:OPCH) from Neutral to Buy and raises the price target from $38 to $40.